Series B funding round for Nuvalent raising $140M in May 2021
Series B funding round for Nuvalent raising $140M in May 2021
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Private | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$190M
Top Valuation
-
Nuvalent raised $140M in a Series B round.
The round was announced on 05/01/21.
The round was led by Bain Capital Life Sciences.